Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BM3/BM3 PLUS

K-Number: K132033 · 2013-12-04

Decision Date2013-12-04
Product CodeMWI
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

BM3/BM3 PLUS is the device name listed in this FDA 510(k) record. The listed applicant is Noblitt & Rueland. It received FDA 510(k) clearance on 2013-12-04 under 510(k) number K132033. The device is classified under product code MWI. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BM3/BM3 PLUS?

BM3/BM3 PLUS is a medical device that received FDA 510(k) clearance on 2013-12-04. The listed applicant is Noblitt & Rueland. The 510(k) number is K132033.

When did BM3/BM3 PLUS receive FDA 510(k) clearance?

BM3/BM3 PLUS received FDA 510(k) clearance on 2013-12-04, under 510(k) number K132033.

Who is the listed applicant for BM3/BM3 PLUS?

The FDA 510(k) record lists Noblitt & Rueland as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BM3/BM3 PLUS?

The FDA product code for BM3/BM3 PLUS is MWI.

Related Devices (Code: MWI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑